Development of transcatheter aortic valve implantation (TAVI): A heart-warming adventure

European Geriatric Medicine

Volumn 4, Issue 6, 2013, Pages 401-406

  Cribier, A ^a  

^a UNIVERSITÉ DE ROUEN   (France)

Author keywords

Aortic stenosis; Heart valve prosthesis; Transcatheter aortic valve implantation

Indexed keywords

AORTA STENOSIS; AORTA VALVE PROSTHESIS; ARTICLE; CARDIOVASCULAR CATHETER; FEASIBILITY STUDY; FOOD AND DRUG ADMINISTRATION; HUMAN; MEDICAL SOCIETY; MEDICAL TECHNOLOGY; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REGISTER; RISK ASSESSMENT; SURGICAL PATIENT; SURGICAL RISK; TRANSCATHETER AORTIC VALVE IMPLANTATION; UNITED STATES; WORK EXPERIENCE;

EID: 84890055401     PISSN: 18787649     EISSN: 18787657     Source Type: Journal    
DOI: 10.1016/j.eurger.2013.09.010     Document Type: Article

References (53)

1. A. Cribier, H. Eltchaninoff, A. Bash, N. Borenstein, C. Tron, and F. Bauer Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description Circulation 106 2002 3006 3008
2. A. Vahanian, D. Himbert, E. Brochet, J.P. Depoix, B. Iung, and P. Nataf Transcatheter aortic valve implantation: our vision of the future Arch Cardiovasc Dis 105 2012 181 186
3. V.T. Nkomo, J.M. Gardin, T.N. Skelton, J.S. Gottdiener, C.G. Scott, and M. Enriquez-Sarano Burden of valvular heart diseases: a population-based study Lancet 368 2006 1005 1011
4. A. Vahanian, O. Alfieri, F. Andreotti, M.J. Antunes, G. Baron-Esquivias, and H. Baumgartner Guidelines on the management of valvular heart disease (version 2012) Eur Heart J 33 2012 2451 2496
5. R.O. Bonow, B.A. Carabello, K. Chatterjee, A.C. de Leon Jr., D.P. Faxon, and M.D. Freed Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Socety of Thoracic Surgeons Circulation 118 2008 e523 e661
6. J. Ross Jr., and E. Braunwald Aortic stenosis Circulation 38 1968 61 67
7. D.S. Bach, N. Cimino, and G.M. Deeb Unoperated patients with severe aortic stenosis J Am Coll Cardiol 50 2007 2018 2019
8. B.J. Bouma, R.B. van Den Brink, J.H. van Der Meulen, H.A. Verheul, E.C. Cheriex, and H.P. Hamer To operate or not on elderly patients with aortic stenosis: the decision and its consequences Heart 82 1999 143 148
9. E. Charlson, A.T. Legedza, and M.B. Hamel Decision-making and outcomes in severe symptomatic aortic stenosis J Heart Valve Dis 15 2006 312 321
10. B. Iung, A. Cachier, G. Baron, D. Messika-Zeitoun, F. Delahaye, and P. Tornos Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 26 2005 2714 2720
11. P.A. Pellikka, M.E. Sarano, R.A. Nishimura, J.F. Malouf, K.R. Bailey, and C.G. Scott Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up Circulation 111 2005 3290 3295
12. B. Iung, G. Baron, P. Tornos, C. Gohlke-Barwolf, E.G. Butchart, and A. Vahanian Valvular heart disease in the community: a European experience Curr Probl Cardiol 32 2007 609 661
13. A. Cribier, T. Savin, N. Saoudi, P. Rocha, J. Berland, and B. Letac Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet 1 1986 63 67
14. B. Letac, A. Cribier, R. Koning, and J.P. Bellefleur Results of percutaneous transluminal valvuloplasty in 218 adults with valvular aortic stenosis Am J Cardiol 62 1988 598 605
15. Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry. Circulation 1991;84:2383-97.
16. W.W. O'Neill Predictors of long-term survival after percutaneous aortic valvuloplasty: report of the Mansfield Scientific Balloon Aortic Valvuloplasty Registry J Am Coll Cardiol 17 1991 193 198
17. H.R. Andersen, L.L. Knudsen, and J.M. Hasenkam Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs Eur Heart J 13 1992 704 708
18. S.D. Moulopoulos, L. Anthopoulos, S. Stamatelopoulos, and M. Stefadouros Catheter-mounted aortic valves Ann Thorac Surg 11 1971 423 430
19. S.J. Phillips, M. Ciborski, P.S. Freed, P.N. Cascade, and D. Jaron A temporary catheter-tip aortic valve: hemodynamic effects on experimental acute aortic insufficiency Ann Thorac Surg 21 1976 134 137
20. N. Moazami, M. Bessler, M. Argenziano, A.F. Choudhri, S.E. Cabreriza, and J.D. Allendorf Transluminal aortic valve placement. A feasibility study with a newly designed collapsible aortic valve ASAIO J 42 1996 M381 M385
21. D. Pavcnik, K.C. Wright, and S. Wallace Development and initial experimental evaluation of a prosthetic aortic valve for transcatheter placement. Work in progress Radiology 183 1992 151 154
22. J. Sochman, J.H. Peregrin, M. Rocek, H.A. Timmermans, D. Pavcnik, and J. Rosch Percutaneous transcatheter one-step mechanical aortic disc valve prosthesis implantation: a preliminary feasibility study in swine Cardiovasc Intervent Radiol 29 2006 114 119
23. P. Bonhoeffer, Y. Boudjemline, Z. Saliba, A.O. Hausse, Y. Aggoun, and D. Bonnet Transcatheter implantation of a bovine valve in pulmonary position: a lamb study Circulation 102 2000 813 816
24. P. Bonhoeffer, Y. Boudjemline, Z. Saliba, J. Merckx, Y. Aggoun, and D. Bonnet Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction Lancet 356 2000 1403 1405
25. H. Eltchaninoff, D. Nusimovici-Avadis, V. Babaliaros, B. Spenser, B. Felsen, and A. Cribier Five month study of percutaneous heart valves in the systemic circulation of sheep using a novel model of aortic insufficiency Eur Interv 1 2006 438 444
26. A. Cribier, H. Eltchaninoff, C. Tron, F. Bauer, C. Agatiello, and L. Sebagh Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis J Am Coll Cardiol 43 2004 698 703
27. A. Cribier, H. Eltchaninoff, C. Tron, F. Bauer, C. Agatiello, and D. Nercolini Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience J Am Coll Cardiol 47 2006 1214 1223
28. J.G. Webb, M. Chandavimol, C.R. Thompson, D.R. Ricci, R.G. Carere, and B.I. Munt Percutaneous aortic valve implantation retrograde from the femoral artery Circulation 113 2006 842 850
29. T. Walther, V. Falk, J. Kempfert, M.A. Borger, J. Fassl, and M.W. Chu Transapical minimally invasive aortic valve implantation; the initial 50 patients Eur J Cardiothorac Surg 33 2008 983 988
30. E. Grube, G. Schuler, L. Buellesfeld, U. Gerckens, A. Linke, and P. Wenaweser Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome J Am Coll Cardiol 50 2007 69 76
31. O. Wendler, T. Walther, H. Schroefel, R. Lange, H. Treede, and M. Fusari Transapical aortic valve implantation: mid-term outcome from the SOURCE registry Eur J Cardiothorac Surg 43 2013 505 511 [Discussion 11-2]
32. H. Baumgartner SOURCE/SOURCE XT registries expanding the TAVI horizon - how real-life clinical practice is evolving clinical indications and complication management? Presented at the EuroPCR 21-24 May, Paris, France 2013
33. S. Windecker One-year outcomes from the SOURCE XT post-approval study Presented at the EuroPCR 21-24 May, Paris, France 2013
34. M. Thomas, G. Schymik, T. Walther, D. Himbert, T. Lefevre, and H. Treede One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve Circulation 124 2011 425 433
35. M.B. Leon, C.R. Smith, M. Mack, D.C. Miller, J.W. Moses, and L.G. Svensson Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
36. C.R. Smith, M.B. Leon, M.J. Mack, D.C. Miller, J.W. Moses, and L.G. Svensson Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med 364 2011 2187 2198
37. R.R. Makkar, G.P. Fontana, H. Jilaihawi, S. Kapadia, A.D. Pichard, and P.S. Douglas Transcatheter aortic-valve replacement for inoperable severe aortic stenosis N Engl J Med 366 2012 1696 1704
38. E.M. Tuzcu PARTNER cohort B three year: clinical and echocardiographic outcomes from a prospective, randomized trial of transcatheter aortic valve replacement in "inoperable" patients TCT Miami, FL, October 24 2012
39. S.K. Kodali, M.R. Williams, C.R. Smith, L.G. Svensson, J.G. Webb, and R.R. Makkar Two-year outcomes after transcatheter or surgical aortic-valve replacement N Engl J Med 366 2012 1686 1695
40. V.H. Thourani Three-year outcomes after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis American College of Cardiology Scientific Session/i2 Summit San Francisco, CA, 11 March 2013
41. D. Mylotte, R.L. Osnabrugge, S. Windecker, T. Lefevre, P. de Jaegere, and R. Jeger Transcatheter aortic valve replacement in europe: adoption trends and factors influencing device utilization J Am Coll Cardiol 62 2013 210 219
42. M.R. Reynolds, E.A. Magnuson, Y. Lei, M.B. Leon, C.R. Smith, and L.G. Svensson Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis Circulation 124 2011 1964 1972
43. K. Hemmann, M. Sirotina, S. De Rosa, J.R. Ehrlich, H. Fox, and J. Weber The STS score is the strongest predictor of long-term survival following transcatheter aortic valve implantation, whereas access route (transapical versus transfemoral) has no predictive value beyond the periprocedural phase Interact Cardiovasc Thorac Surg 2013
44. A.W. Schoenenberger, S. Stortecky, S. Neumann, A. Moser, P. Juni, and T. Carrel Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation (TAVI) Eur Heart J 34 2013 684 692
45. D.R. Holmes Jr., M.J. Mack, S. Kaul, A. Agnihotri, K.P. Alexander, and S.R. Bailey ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collabration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance J Thorac Cardiovasc Surg 144 2012 e29 e84
46. J.R. Lunney, J. Lynn, D.J. Foley, S. Lipson, and J.M. Guralnik Patterns of functional decline at the end of life JAMA 289 2003 2387 2392
47. S. Stortecky, A.W. Schoenenberger, A. Moser, B. Kalesan, P. Juni, and T. Carrel Evaluation of multidimensional geriatric assessment as a predictor of mortality and cardiovascular events after transcatheter aortic valve implantation JACC Cardiovasc Interv 5 2012 489 496
48. H. Eltchaninoff, A. Prat, M. Gilard, A. Leguerrier, D. Blanchard, and G. Fournial Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry Eur Heart J 32 2011 191 197
49. R. Lange, S. Bleiziffer, D. Mazzitelli, Y. Elhmidi, A. Opitz, and M. Krane Improvements in transcatheter aortic valve implantation outcomes in lower surgical risk patients: a glimpse into the future J Am Coll Cardiol 59 2012 280 287
50. J.G. Webb, D.A. Wood, J. Ye, R. Gurvitch, J.B. Masson, and J. Rodes-Cabau Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves Circulation 121 2010 1848 1857
51. Press release. Medtronic CoreValve® system gains first approval for transcatheter valve-in-valve procedures. 23 May 2013.
52. R. Gurvitch, D.A. Wood, E.L. Tay, J. Leipsic, J. Ye, and S.V. Lichtenstein Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort Circulation 122 2010 1319 1327
53. A. Ungar, P. Bramlage, M. Thoenes, S. Zannoni, and J.P. Michel A call to action - Geriatricians' experience in treatment of aortic stenosis and involvement in transcatheter aortic valve implantation Eur Geriatr Med 4 2013 176 182